James Garnick
Overview
Explore the profile of James Garnick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montgomery T, Cohen A, Garnick J, Spadafore J, Boldea E
Nutr Clin Pract
. 2012 Apr;
27(3):352-62.
PMID: 22523158
A ventricular assist device (VAD) is an implantable mechanical device that is used to partially or completely replace the circulatory function of a failing heart. VADs may serve as a...
2.
Alangaden G, Thyagarajan R, Gruber S, Morawski K, Garnick J, El-Amm J, et al.
Clin Transplant
. 2006 Jul;
20(4):401-9.
PMID: 16842513
Background: The impact of newer immunosuppressive and antimicrobial prophylactic agents on the pattern of infectious complications following kidney transplantation has not been well studied. Methods: This is an observational study...
3.
Haririan A, Fagoaga O, Daneshvar H, Morawski K, Sillix D, El-Amm J, et al.
Clin Transplant
. 2006 Apr;
20(2):226-33.
PMID: 16640531
The HLAMatchmaker program is based on the donor/recipient comparison of the polymorphic triplet amino-acid sequences of the antibody-accessible regions on the human leucocyte antigen (HLA) molecule. The previous reports on...
4.
Gruber S, West M, Sillix D, El-Amm J, Garnick J, Morawski K, et al.
Surgery
. 2005 Nov;
138(4):772-8.
PMID: 16269308
Background: There is a paucity of data regarding the use of steroid-avoidance immunosuppression (SAI) in African American (AA) renal allograft recipients, traditionally considered a high-risk subgroup of patients with higher...
5.
Haririan A, Morawski K, Sillix D, El-Amm J, Garnick J, West M, et al.
Transplantation
. 2005 Mar;
79(6):716-21.
PMID: 15785379
Background: It has been suggested that the use of antilymphocyte induction therapy in African-American (AA) renal transplant recipients reduces the risk of acute rejection (AR) and improves graft survival. It...
6.
Gruber S, Garnick J, Morawski K, Sillix D, West M, Granger D, et al.
Clin Transplant
. 2005 Mar;
19(2):273-8.
PMID: 15740567
There is a paucity of data examining the efficacy of valganciclovir (VGC) for cytomegalovirus (CMV) prophylaxis in kidney transplant patients, particularly with regard to utilization of a risk-stratified dosing regimen....
7.
Wadei H, Alangaden G, Sillix D, El-Amm J, Gruber S, West M, et al.
Clin Transplant
. 2004 Nov;
18(6):753-8.
PMID: 15516257
West Nile virus (WNV) has emerged as an important cause of several outbreaks of febrile illness and encephalitis in North America over the past few years. The most common manifestation...
8.
Wadei H, Gruber S, El-Amm J, Garnick J, West M, Granger D, et al.
Am J Transplant
. 2004 May;
4(6):1002-5.
PMID: 15147436
Sirolimus (SRL) is a macrolide immunosuppressant that has gained widespread use in organ transplantation. Its full spectrum of side-effects is yet to be defined. We describe herein three cases of...